Boston BioForum 2012 To Be Held on April 7 at MIT

Boston BioForum 2012 – Meeting the Challenges Through Innovation
CABA(Chinese-American BioMedical Association) Annual Conference

Date: Saturday, April 7, 2012; 8:30 AM – 9:00 PM
Venue: MIT Faculty Club, 50 Memorial Drive, Bldg E52, 6th Floor; Cambridge, MA
CABA Website:

Newspaper Ad
[pdf-ppt-viewer href="" width="700" height="500"]

Program guide
[pdf-ppt-viewer href="" width="700" height="800"]

Boston BioForum 2012  –  CABA Annual Conference

Meeting the Challenges Through Innovation


Date: Saturday, April 7, 2012; 8:30 AM – 9:00 PM

Venue: MIT Faculty Club, 50 Memorial Drive, Bldg E52, 6th Floor; Cambridge, MA

Conference Agenda

8:00-9:00          Registration

9:00-9:05          Opening Remarks

Morning Session I

9:05-9:40          Combination Strategies to Cure Hepatitis C

Ron Renaud

Idenix Pharmaceuticals – CEO

9:40-10:10        The Story of Tysabri

Alfred Sandrock, M.D., Ph.D.

Biogen Idec. – Sr. Vice President, Development Sciences, Chief Medical Officer

10:10-10:45      Keeping Innovation-The Business of Vertex from a Science Perspective

Mark Namchuk, Ph.D.

Vertex Pharmaceuticals – SVP, Research

10:45-10:55      Coffee Break and Vendor Show  

Morning Session II

10:55-11:30      Met-ing our Neighbors: Putting R&D into BD

Detlev Biniszkiewicz, Ph.D.

AstraZeneca – VP, IMED Strategy for Oncology

11:30-12:30      Panel Discussion: Integrated Drug R&D Services

Chen Chen, Ph.D.        Sundia MediTech – CEO

Jifeng Liu, Ph.D.          Aberjona – President

George Shi, Ph.D.        Anichem – CSO

Maxine Rojas               WuXi Apptec – Director, Business Development

Larry Cai, MBA                       Shanghai Medicilon – Sr. Director, Business Development

Ming Qi, Ph.D.             Accelachem – President

Derek Ren, Ph.D.         Viva – VP, Discovery Biology

Hui Li, Ph.D.                   BioDuro/PPD – Head of Business Development

12:30-1:30        Lunch Break, Vendor Show and Career Fair


1:30-2:05          Filling the Gap between Basic Research and Drug Discovery: the Broad Approach

Michael Foley, Ph.D.

The Broad Institute – Director of Chemical Biology

2:05-2:35          Translating the Cancer Genome into Impactful Drugs

Markus Warmuth, M.D.

H3 Biomedicine – CEO

2:35-3:05          Planning and Challenges for Development of Innovative Drugs: the ARIAD Experience      

Daniel M. Bollag, Ph.D.

Ariad – SVP, Regulatory Affairs and Quality

3:05-3:15          Coffee Break and Vendor Show

Afternoon Session II

3:15-3:45          Solution to “Tough-to-Drug” Targets: Integrated Discovery Engine of Macrocycles, DNA-Programmed Chemistry, Affinity-Based Selections & Next Generation Sequencing

Steve Hale, Ph.D.

Ensemble Therapeutics – VP, Screening & Biochemistry

3:45-3:55          Career Opportunities – China Biotech Opportunities

3:55-4:10          Career Opportunities – Deqing Biopark Introduction

4:10-5:00          Panel Discussion: Career Development & Entrepreneurship

Frank Feist                              NobelGen – CEO

Gangfeng Xu, Ph.D.                 Abbott Laboratories – Div. VP, Corp. Licensing & Acquisitions

Lauren Celano                         Propelcareers – CEO

Lixin Shen, Ph.D.                     Howfond Biopharma – CEO

Joshua Zhang, MD, PhD          Ariad – Sr. Director, Clinical Research

5:00-5:30          Celebration of Five Years of Community Service and Leadership

5:30-6:15          Cocktail Social Hour: Networking and Vendor Show

Evening Session

6:15-7:00          Dinner

7:00-7:45          Chemical Probes for Epigenetics

Mark Bunnage, Ph.D.

Pfizer – VP, Head of Chem., BioTherapeutics Research

7:45-8:30          Building an Innovative Biotech: Lessons and Secrets

Chiang Li, M.D.

Boston Biomedical – Founder and CEO

8:30-9:30          Social Networking